**Author details**

Marouene Bejaoui1,2\*, Hanen Oueslati3 and Haykel Galai2

1 Département de Recherche, Faculté des Sciences de Bizerte, Université de Carthage, Jarzouna, Tunisia

2 Institut National de Recherche et d'Analyses Physico-Chimiques de Sidi-Thabet, Sidi Thabet, Tunisia

3 Laboratoire National de Contrôle des Médicaments, Bab Saadoun, Tunis, Tunisia

\*Address all correspondence to: marouene2010@gmail.com

© 2021 The Author(s). Licensee IntechOpen. This chapter is distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/ by/3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

**125**

*Ternary Solid Dispersion Strategy for Solubility Enhancement of Poorly Soluble Drugs…*

the relative impact of formulation variables, wet media milling process parameters and excipient variability on drug product quality attributes. Drug Development and Industrial Pharmacy. 2018;44:1942-1952. DOI: 10.1080/03639045.2018.1503296

[7] Hussain A, Smith G, Khan KA,

Ermolina I. Solubility and dissolution rate enhancement of ibuprofen by co-milling with polymeric excipients. European Journal of Pharmaceutical Sciences. 2018 ;123:395-403. DOI:

Knapik-Kowalczuk J, Kurek M, Syrek K, Chmiel K, Paluch M, Jachowicz R. Planetary ball milling and supercritical fluid technology as a way to enhance

International Journal of Pharmaceutics. 2017;533:470-479. DOI: 10.1016/j.

Zhao Y, Wang Z, Han J. Enhanced oral

nanocrystalline solid dispersion based on wet media milling technique: formulation, optimization and in vitro/ in vivo evaluation. Pharmaceutics.

[10] Loh ZH, Samanta AK, Heng PW. Overview of milling techniques for improving the solubility of poorly water-soluble drugs. Asian journal of pharmaceutical sciences. 2015 ;10:255- 274. DOI: 10.1016/j.ajps.2014.12.006

[11] Karagianni A, Kachrimanis K, Nikolakakis I. Co-amorphous solid dispersions for solubility and absorption improvement of drugs: Composition, preparation, characterization and formulations for oral delivery. Pharmaceutics. 2018;10:98. DOI: 10.3390/pharmaceutics10030098

Bukhari NI, Pedge NI,

10.1016/j.ejps.2018.08.001

[8] Szafraniec J, Antosik A,

dissolution of bicalutamide.

[9] Ding Z, Wang L, Xing Y,

bioavailability of celecoxib

2019;11:328. DOI: 10.3390/ pharmaceutics11070328

ijpharm.2017.03.078

*DOI: http://dx.doi.org/10.5772/intechopen.95518*

[1] Penkina A, Semjonov K, Hakola M, Vuorinen S, Repo T, Yliruusi J, Aruväli J, Kogermann K, Veski P, Heinämäki J. Towards improved solubility of poorly

water-soluble drugs: cryogenic co-grinding of piroxicam with carrier polymers. Drug development and industrial pharmacy. 2016; 42:378-388. DOI: 10.3109/03639045.2015.1054400

[2] Gaggero A, Dukovski BJ, Radić I, Šagud I, Škorić I, Cinčić D, Jug M. Co-grinding with surfactants as a new approach to enhance in vitro dissolution of praziquantel. Journal of Pharmaceutical and Biomedical Analysis. 2020;189:113494. DOI: 10.1016/j.jpba.2020.113494

msec.2019.110012

[4] Moinuddin SM, Ruan S,

and pharmacokinetic profile.

ijpharm.2017.09.020

Huang Y, Gao Q, Shi Q, Cai B, Cai T. Facile formation of co-amorphous atenolol and hydrochlorothiazide mixtures via cryogenic-milling:

enhanced physical stability, dissolution

International Journal of Pharmaceutics. 2017;532:393-400. DOI: 10.1016/j.

[5] Kasten G, Nouri K, Grohganz H, Rades T, Löbmann K. Performance comparison between crystalline and co-amorphous salts of indomethacinlysine. International Journal of

Pharmaceutics. 2017;533:138-144. DOI:

10.1016/j.ijpharm.2017.09.063

[6] Patel PJ, Gajera BY, Dave RH. A quality-by-design study to develop Nifedipine nanosuspension: examining

[3] Xiong X, Zhang M, Hou Q, Tang P, Suo Z, Zhu Y, Li H. Solid dispersions of telaprevir with improved solubility prepared by co-milling: formulation, physicochemical characterization, and cytotoxicity evaluation. Materials Science and Engineering: C. 2019;105:110012. DOI: 10.1016/j.

**References**

*Ternary Solid Dispersion Strategy for Solubility Enhancement of Poorly Soluble Drugs… DOI: http://dx.doi.org/10.5772/intechopen.95518*
